Follow us on X
Follow us on LinkedIn
Follow us on Youtube
Discover RISE d.o.o

OSTEOproSPINE

Novel Bone Regeneration Drug Osteogrow: Therapeutic Solution for Lumbar Back Pain


Description

OSTEOproSPINE aims to improve therapeutic options for patients suffering from degenerative disc diseases by translating the patient’s peripheral blood into extra-skeletal bone. The research will be based on a therapeutic system developed in the course of the previous research project OSTEOGROW, in which an autologous carrier and a biologically active human protein were combined to accelerate and enhance bone repair. For OSTEOproSPINE, the protein was reinforced with allograft. In the course of the project, the therapy will be tested in a Phase II clinical trial in four clinical centres.

Coordinator
Prof. Dr. Slobodan Vukicevic
University of Zagreb
Phone: +385 1 492 0046
Email
Programme
Horizon 2020 & sub-programmes
Duration
66 months (January 2018 - June 2023)
Project funding
€ 6,004,152.50
Project partners
12
Technology readiness level
0-2
About Eurice

Eurice offers knowledge-based consultancy services in project and innovation management.

Eurice Head Office
Heinrich-Hertz-Allee 1
66386 St. Ingbert
Germany
Phone: +49 6894 388130
Email
Eurice Berlin
Alt-Reinickendorf 25
13407 Berlin
Germany
Phone: +49 30 374415840
Email